Clinical aspects of retinal degeneration Flashcards

1
Q

what causes blindness?

A

refractive error
cataracts
both treatable
314 million people have impaired sight
outer retinal disease makes up most of blindess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the epidemiology of blindness in the uk?

A

retinal diseases make 70% of blindness in the uk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are causes of retinal blindness?

A

age related macular degeneration
diabetic retinopathy
retinal vascular occlusions
hereditary retinal disease
retinal detachments
trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the choriocapillaris

A

supplying oxygen and nutrient to outer retina and providing metabolic exchange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the role of the inner retina

A

processing and output via ganglion cells to optic nerve and brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the role of the outer retina

A

light detection and phototransduction to produce action potentials to inner retina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

outline the retinal pigment epithelium

A
  • light absorption
  • epithelial transport
  • spatial buffering of ions
  • visual cycle
  • phagocytosis of photoreceptor outer segment
  • secretion
  • immune privelige of the eye
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what does the retinal pigment epithelium secrete

A

large variety of signalling molecules including ATP, FGF, transforming growth factor -beta, VEGF and PEDF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the prevalence and incidence of age related macular degeneration

A

over 75s - 1/4 of them have AMD
late AMD = loss of vision
prevalent in aged population
11 million people with late AMD (6%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is OCT

A

optical coherence tomography - measures coherence while light gets reflected back
high resolution - 3 micron in axial plane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how is AMD classified

A

early - few small drusen
intermediate - larger and more frequent drusen , pigmentary changes in RPE
advanced - dry or geographic atrophy, and wet or neovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is seen in early AMD

A

drusen normally in macular area but can be away from fovea
RPE is very bright on optical coherence tomograph - can see the drusen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are drusen

A

lipid and microprotein deposits
top layer is the basement layer of Retinal pigment epithelium
they accumulate to form drusen on bruch’s membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

outline intermediate AMD

A

bigger drusen and more frequent
pigmentary abnomarlities
NOT symptomatic - maybe just darkness e.g cant see where they are going at night but overall good vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

outline late AMD

A

new vessels of choroid vessels grow under and through Bruchs membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

outline wet AMD

A

because the new choroid vessels grow under RPE or through Bruchs membrane under retina - this can leak and bleed and cause FIBROSIS
causing visual loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the two types of late AMD and what are they also called

A

neovascular (wet) - treatment for some
geographic atrophy - no treatment until recently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

outline dry amd

A

choroid and RPE atrophies occur coincidentally
loss of photoreceptor outer segments in that area
secondary photoreceptor atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

outline geographic atrophy (dry amd)

A

people with bilateral GA:
- 2/3 unable to drive within 2 years
- 1 in 5 registered blind at 6 years
GA is PLEOMORPHIC - faster progression in some subtypes
- extrafoveal and multifocal GA facter than central
= progressive atrophy of outer retinal layers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

outline AMD aetiology

A

as we age, deposits of lipids between RPE and basement membrane, BRUCH’S membrnes thicker, - this has implications on transmission of nutrients and oxygen from choroid
drusen in bruchs - lipoproteins complement proteins, APOE
waste poroducts not recycled correctly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

outline AMD pathogenesis

A

age and oxidative stress -> mtDNA damage -> impaired RPE phagocytosis and autophagy
leads to RPE cell dysfunction, accumulation of lipofuscin and alternate complement activation - drusen build up
leads to RPE cell death

22
Q

what is the macula highly vulnerable to

A

oxidative stress
it has a high blood supply and oxygen uptake coupled with light exposure to lipid rich outer segments of photoreceptors , hence oxidatively susceptible

23
Q

what are risk factors of AMD

A

age
environmental = smoking, diet, obesity, hypertension, UV exposure
genetic predispositions

24
Q

outline genetic predispositions of AMD

A

impaired autophagy
susceptibility to oxidative stress
polygenic and complex - sibling with AMD means increased risk 3-6x

25
Q

outline complement dysregulation in AMD

A

drusen
CFH, CFI. C3 C9 of complement system strongly associated with pathogenesis
C3 and C5 proteins accumulate in drusen, sub-RPE and AMD.
damage from stressors accumulatees with age = drusen and lipofuscin deposits

26
Q

what is the complement system

A

immunological network
30 proteins - made in liver,
abundant
act as interface of inate and adaptive immune systems- activated in response to infection and injury - provides inflammation and immune cell recruitment
eliminates diseasses cells and pathogens without injuring host

27
Q

which complement pathway affects amd

A

ALTERNATE PATHWAY

28
Q

what are the AMD genes

A

polygenic
mutations in alternate complement pathway
one of common risk factors is variant in FH = CHANGE OF TYROSINE TO HISTIDINE OF CFH gene on 1q - affects ability of 402H to bind less well to substrates in RPE rea = ineffective alternative complement suppression

29
Q

how many single gene defect dystrophies have been identified

A

200

30
Q

why is ciliary trafficking important

A

important in photoreceptor outer segment - if modified affect cilia so cilial genes are important in RPE and RPE function phototransduction cascade

31
Q

outline retinitis pigmentosa

A

night blindness then progressive field constriction followed by central visual loss
can start in 20s
rods affected first, as rods die cones rely on them more to survive , if rods die then cones die
spicules, arteriolar attenuation and pale discs

32
Q

how is retinitis pigmentosa inherited

A

as AR AD or X-linked - and mitochondrially inherited aswell

33
Q

what is Stargardt disease

A

example of macular dystrophy
autosomal recessive, common
‘flecks’ of focal lipofuchsin build up
ABCA4 gene - codes for protein in outer segment discs of photoreceptors - build up of abnormal phototransduction products in RPE = RPE and photoreceptor loss

34
Q

outline gene therapy to correct simple loss of function defects

A

‘luxturna’ is liscensed
uses AAV2 (adeno-associated) virus vector - injected subretinally to transfect RPE cells with wild type RPE65 gene
successful
but expensive to treat both eyes

35
Q

what are the problems with using gene therapy

A

20-50% of cases gene defect is unknown
a lot of defects not correctable
gene therapy wont improve function if cells are dead
complex and expensive

36
Q

what is the main way to prevent progression for intermediate AMD

A

dietary supplements of antioxidants vitamins
Lutein and Zeanthin (naturally occur in retina)
green leafy vegetables - kale, broccoli
stops oxidation
for dry AMD

37
Q

what is the main treatment for wet AMD?

A

anti VEGF (anti vascular endothelial growth factor)
prevents further choroidal new vessel growth , causes vasoconstriction and reduces vascular leak
e.g Ranibizumab, Bevacizumab
stops neovascular growth
80% respond

38
Q

what are the problems with anti-VEGF agents

A

dont remove scar (fibrosis)
not 100% effective
have to be repeated monthly
dont reverse underlying degeneration

39
Q

what are some other potential treatments for dry AMD

A

anti-complement therapies
other anti-inflammatory agents
visual cycle modulation
neuroprotection
cellular treatments for rescue and transplant

40
Q

outline complement inhibition/modulation

A

dry AMD progression reduced by 30%
agents which work at C3 level blocking C3b production and C5 going to C5a
redued progression of geographic atrophy - monthly injection

41
Q

outline anti-inflamamtory treatments for dry AMD

A

statins - lipid lowering agents with anti-inflammatory properties
integrin inhibitors that target macrophages and decrease inflammasome activation
unknown efficacy

42
Q

outline visual cycle modulation for dry AMD

A

modulate visual cycle by disrupting conversion of retinol to rhodopsin - decreases toxic waste products such as lipofuchsin and A2E in RTE
unknown efficacy

43
Q

what can we do for late stage AMD

A

electronic implants and optogenetics

44
Q

what could we do for early stage AMD patients so they maintain vision

A

replace RPE as it stimulates choriocapilaris growth so could restore that - either with suspension or sheet of cells

45
Q

what is autologous RPE transplantation

A

e.g RPE patch
works well in some eyes
surgery - to harvest the patch

46
Q

what are the 3 main sources of pluripotent stem cells

A

human embryonic
nuclear transfer - take somatic cell nucleus and put into oocyte with no nucleus in
induced - what researchers r concentrating on right now

47
Q

outline what RPE cells are like

A

confluent cuboidal pigmented monolayer
gene expression - RPE65, MERTK
phagocytosis
apical polarity
transepithelial resistance
fluid transport

48
Q

how does eye develop

A

optic vesicle
invagination forms optic cup
embryonic eye

49
Q

what is the potential role of retinal organoids

A

take skin or blood cells and reprogramme them to IPS cells (induced pluripotent stem cells)

50
Q

what do we need to consider with pluripotent stem cell transplants?

A

immune reactivity
impractical to produce IPSc for everyone